Feedback / Questions
varlitinib (ASLAN001) - ASLAN
https://www.globenewswire.com/news-release/2019/05/10/1821634/0/en/ASLAN-Pharmaceuticals-Varlitinib-Selected-by-Leading-Korean-Gastric-Cancer-Group-for-Study-in-Second-Line-Gastric-Cancer.html
May 10, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next